Navigating the ethical terrain: Off-label and experimental treatments in medical case reports (original) (raw)
Editorial
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Methodol. Mar 20, 2025; 15(1): 94833
Published online Mar 20, 2025. doi: 10.5662/wjm.v15.i1.94833
Table 3 Recommendations for ethical vigilance and reporting
| Area of focus | Recommendation |
|---|---|
| Ethical guidelines development | Formulate comprehensive, clear guidelines specifically addressing off-label and experimental treatments, with input from a multidisciplinary team |
| Regulatory oversight | Enhance the role of regulatory bodies in monitoring and guiding the reporting on experimental treatments to ensure accuracy and ethical compliance |
| Education and training | Provide ongoing education for clinicians and researchers on ethical reporting practices and the importance of maintaining integrity in medical research |
- Citation: Jeyaraman M, Jeyaraman N, Ramasubramanian S, Balaji S. Navigating the ethical terrain: Off-label and experimental treatments in medical case reports. World J Methodol 2025; 15(1): 94833
- URL: https://www.wjgnet.com/2222-0682/full/v15/i1/94833.htm
- DOI: https://dx.doi.org/10.5662/wjm.v15.i1.94833